NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/19/2026
Back to search
Official data from USPTO
ADENOCYTE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
05/19/2026
Trademark type
Word
Nice classes
45
Filing date
08/02/2021
Registration date
05/19/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/19/2026
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2025-01-00
First use in commerce
2025-01-00
Drawing code
4
Owner type
16
Owner location
Jerusalem, IL
Examiner
SUAREZ, MARIA VICTORIA
Law office
O60
Current location
TMO LAW OFFICE 133
Holders and representatives
Holders
Adenocyte Ltd.
Adenocyte Ltd.
Representatives
Tuvia Rotberg TARTER KRINSKY & DROGIN LLP
Technical classification
Nice Classes
Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 45
Licensing of intellectual property
Publications
History of USPTO decisions and trademark events.
49 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/28/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/28/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/01/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/01/2026
ALIE
ASSIGNED TO LIE
04/01/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/31/2026
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
12/31/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
12/31/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/02/2025
GNRT
NON-FINAL ACTION E-MAILED
10/02/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/02/2025
DOCK
ASSIGNED TO EXAMINER
08/15/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/12/2025
IUAF
USE AMENDMENT FILED
08/11/2025
EISU
TEAS STATEMENT OF USE RECEIVED
08/11/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/25/2025
EX5G
SOU EXTENSION 5 GRANTED
05/24/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/24/2025
EEXT
SOU TEAS EXTENSION RECEIVED
02/10/2025
EXT5
SOU EXTENSION 5 FILED
02/09/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/06/2024
EX4G
SOU EXTENSION 4 GRANTED
08/06/2024
EXT4
SOU EXTENSION 4 FILED
08/06/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/10/2024
EX3G
SOU EXTENSION 3 GRANTED
02/08/2024
EXT3
SOU EXTENSION 3 FILED
02/08/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/08/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/17/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/17/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/17/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/11/2023
EX2G
SOU EXTENSION 2 GRANTED
08/09/2023
EXT2
SOU EXTENSION 2 FILED
08/09/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/09/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/13/2022
EX1G
SOU EXTENSION 1 GRANTED
12/09/2022
EXT1
SOU EXTENSION 1 FILED
12/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
12/09/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/09/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/14/2022
PUBO
PUBLISHED FOR OPPOSITION
06/14/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/25/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/06/2022
DOCK
ASSIGNED TO EXAMINER
04/29/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/28/2021
NWAP
NEW APPLICATION ENTERED
08/05/2021
Continuous trademark protection
Get notified about every new filing that threatens ADENOCYTE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.